A groundbreaking medical study center is being planned for Mauritius to encourage health care companies to focus their attention on the plight of Africa. The island - best known for its holiday beaches in the Indian Ocean and the last home of the dodo - has been chosen by an Oxford, UK-based charity as the ideal location.
Mauritius has been selected because of its political and economic stability and the need for a research center of global standing in the African continent, the charity said. The commercial arm of the Oxford International Biomedical Center wants to bring together international organizations to help address the "appalling" medical problems facing Africa. "The tired approach of tirade, aid and trade is not working," says Charles Pasternak, director of the OIBC.
The new center will provide research facilities into diseases such as tuberculosis, AIDS and malaria and aims to attract smaller businesses, as well as the giants of the scientific world. It will also work closely with the University of Mauritius and the island's Ministry of Health to train scientists and investigate health disasters prevalent throughout the region, says the OIBC.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze